When underlying biology threatens the randomization principle — initial gout flares of urate-lowering therapy


  • Faires, JS & McCarty, DJ Acute arthritis in man and dog after intrasynovial injection of sodium urate crystals. Lancet 280682–685 (1962).

    ArticleGoogle Scholar

  • Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440237–241 (2006).

    CAS PubMed Article Google Scholar

  • Stewart, S. et al. The experience of a gout flare: a meta-synthesis of qualitative studies. semin. Arthritis Rheum. fifty805–811 (2020).

    PubMed ArticleGoogle Scholar

  • Qaseem, A., Harris, RP & Forciea, MA Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians. Ann. Intern. Med. 16658–68 (2017).

    PubMed ArticleGoogle Scholar

  • Dalbeth, N. et al. Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN). Nat. Rev. Rheumatol. 13561–568 (2017).

    PubMed ArticleGoogle Scholar

  • McLean, RM The long and winding road to clinical guidelines on the diagnosis and management of gout. Ann. Intern. Med. 16673–74 (2017).

    PubMed ArticleGoogle Scholar

  • Neogi, T. & Mikuls, TR To treat or not to treat (to target) in gout. Ann. Intern. Med. 16671–72 (2017).

    PubMed ArticleGoogle Scholar

  • FitzGerald, JD, Neogi, T. & Choi, HK Publisher: do not let gout apathy lead to gouty arthropathy. Arthritis Rheumatol. 69479–482 (2017).

    PubMed ArticleGoogle Scholar

  • Khanna, D. et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res. 641431–1446 (2012).

    CAS Article Google Scholar

  • Richette, P. et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann. Rheum. Dis. 7629–42 (2017).

    CAS PubMed Article Google Scholar

  • Krishnan, E., Lienesch, D. & Kwoh, CK Gout in ambulatory care settings in the United States. J. Rheumatol. 35498–501 (2008).

    PubMedGoogle Scholar

  • Latif, ZP, Nakafero, G., Jenkins, W., Doherty, M. & Abhishek, A. Implication of nurse intervention on engagement with urate-lowering drugs: a qualitative study of participants in a RCT of nurse led care. Joint Bone Spine 86357–362 (2019).

    PubMed PubMed Central Article Google Scholar

  • Yue, TF & Gutman, AB Effect of allopurinol (4-hydroxypyrazolo-(3,4-d)pyrimidine) on serum and urinary uric acid in primary and secondary gout. Am. J. Med. 37885–898 (1964).

    CAS PubMed Article Google Scholar

  • Borstad, GC et al. Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. J. Rheumatol. 312429–2432 (2004).

    CAS PubMed Google Scholar

  • Schumacher, HR Jr & Chen, LX The practical management of gout. Cleveland. Clin. J. Med. 75S22–S25 (2008).

    ArticleGoogle Scholar

  • Perez-Ruiz, F. Treating to target: a strategy to cure gout. Rheumatology 48ii9–ii14 (2009).

    CAS PubMed Article Google Scholar

  • Yamanaka, H. et al. Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomized study. Ann. Rheum. Dis. 77270–276 (2018).

    CAS PubMed Article Google Scholar

  • Becker, MA, MacDonald, PA, Hunt, BJ, Lademacher, C. & Joseph-Ridge, N. Determinants of the clinical outcomes of gout during the first year of urate-lowering therapy. Nucleosides Nucleotides Nucleic Acids 27585–591 (2008).

    CAS PubMed Article Google Scholar

  • FitzGerald, JD et al. 2020 American College of Rheumatology guideline for the management of gout. Arthritis Rheumatol. 72879–895 (2020).

    PubMed ArticleGoogle Scholar

  • Wortmann, RL, Macdonald, PA, Hunt, B. & Jackson, RL Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trials. Clin. Ther. 322386–2397 (2010).

    CAS PubMed Article Google Scholar

  • Schlesinger, N. et al. Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomized study. Ann. Rheum. Dis. 701264–1271 (2011).

    CAS PubMed Article Google Scholar

  • Mitha, E. et al. Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial. Rheumatology 521285–1292 (2013).

    CAS PubMed Article Google Scholar

  • Schumacher, HR et al. Outcome domains for studies of acute and chronic gout. J. Rheumatol. 362342–2345 (2009).

    PubMed ArticleGoogle Scholar

  • Becker, MA et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N. Engl. J. Med. 3532450–2461 (2005).

    CAS PubMed Article Google Scholar

  • Doherty, M. et al. Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomized controlled trial. Lancet 3921403–1412 (2018).

    PubMed PubMed Central Article Google Scholar

  • Sundy, JS et al. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA 306711–720 (2011).

    CAS PubMed Article Google Scholar

  • O’Dell, JR et al. Comparative effectiveness of allopurinol and febuxostat in gout management. NEJM Evid. 1EVIDoa2100028 (2022).

    ArticleGoogle Scholar

  • vanLaar, JM et al. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA 3112490–2498 (2014).

    PubMed Article CAS Google Scholar

  • Sullivan, KM et al. Myeloablative autologous stem-cell transplantation for severe Scleroderma. N. Engl. J. Med. 37835–47 (2018).

    PubMed PubMed Central Article Google Scholar

  • Skou, ST et al. A randomized, controlled trial of total knee replacement. N. Engl. J. Med. 3731597–1606 (2015).

    CAS PubMed Article Google Scholar

  • Polack, FP et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N. Engl. J. Med. 3832603–2615 (2020).

    CAS PubMed Article Google Scholar

  • Baden, LR et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384403–416 (2021).

    CAS PubMed Article Google Scholar

  • Saag, KG et al. Lesinurad combined with allopurinol: a randomized, double-blind, placebo-controlled study in gout patients with an inadequate response to standard-of-care allopurinol (a US-based study). Arthritis Rheumatol. 69203–212 (2017).

    CAS PubMed Article Google Scholar

  • Dafni, U. Landmark analysis at the 25-year landmark point. circle Cardiovasc. What. outcomes 4363–371 (2011).

    PubMed ArticleGoogle Scholar

  • Garcia-Albeniz, X., Maurel, J. & Hernan, MA Why post-progression survival and post-relapse survival are not appropriate measures of efficacy in cancer randomized clinical trials. Int. J. Cancer 1362444–2447 (2015).

    CAS PubMed Article Google Scholar

  • Hernan, MA, Hernandez-Diaz, S. & Robins, JM Randomized trials analyzed as observational studies. Ann. Intern. Med. 159560–562 (2013).

    PubMedGoogle Scholar

  • Smith, VA, Coffman, CJ & Hudgens, MG Interpreting the results of intention-to-treat, per-protocol, and as-treated analyzes of clinical trials. JAMA 326433–434 (2021).

    PubMed ArticleGoogle Scholar

  • Hernan, MA & Robins, JM Per-protocol analyzes of pragmatic trials. N. Engl. J. Med. 3771391–1398 (2017).

    PubMed ArticleGoogle Scholar

  • Stamp, L. et al. Serum urate as surrogate endpoint for flares in people with gout: a systematic review and meta-regression analysis. semin. Arthritis Rheum. 48293–301 (2018).

    CAS PubMed Article Google Scholar

  • Morillon, MB et al. Serum urate as a proposed surrogate outcome measure in gout trials: from the OMERACT working group. semin. Arthritis Rheum. 511378–1385 (2021).

    CAS PubMed Article Google Scholar

  • Bardin, T. et al. Lesinurad in combination with allopurinol: a randomized, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study). Ann. Rheum. Dis. 76811–820 (2017).

    CAS PubMed Article Google Scholar

  • Leave a Comment